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Percutaneous coronary intervention (PCI) is actually the most used method of revascularization. Although complete revascu-
larization remains a desirable goal, it may not be possible or not easy to plan in many patients. Thus, incomplete revascularization
might be a preferred treatment strategy in selected patient categories. Stress myocardial scintigraphy, because of its high diagnostic
accuracy and prognostic value and its ability to assess location and extent of myocardial ischemia regardless of symptoms as well
as to evaluate patients who are unable to exercise or who have uninterpretable electrocardiogram, is of paramount importance for
clinical decision making in patients with multivessel disease and incomplete revascularization.
1.Introduction
Formanypatientswithmultivesseldisease,PCIisadeﬁnitive
alternative to coronary artery by-pass graft (CABG) [1, 2].
Complete revascularization remains a desirable goal, and a
satisfactory outcome may be obtained with complete revas-
cularization with PTCA [3]o rC A B G[ 4, 5].
However,completerevascularizationmaynotbepossible
in many patients, either because of the operator inability
to treat all diseased coronary arteries such as chronic total
occlusions and adverse stenosis morphology or simply being
not easy to plan in the presence of coronary narrowing less
than severe (>50% but <70%). Alternatively, the operator
might decide to selectively revascularize only large areas
of myocardium at risk. Indeed, clinical reasons for this
decision include, among others, unstable angina, recent
myocardial infarction, severe left ventricular dysfunction,
urgent/emergent PCI, preexisting renal failure for which the
amount of angiographic contrast media should be limited,
and premature termination of the procedure for unexpected
problems, such as in those elderly or frail patients who
cannotlayﬂatforprolongedperiods.Thus,revascularization
of the culprit lesion may be part of an incomplete revascular-
ization strategy which may be of value other than a common
clinical practice in many selected cases, when wisely chosen
because of its easier achievement and lower immediate risk.
2. HistoricalandUpdated Background of
AnatomicalIncomplete versusAnatomical
Complete Revascularization
IntheBARITrialcomparingCABGwithmultivesselPCI,the
10-year survival did not diﬀer between the two treatments
despite the fact that 91% of signiﬁcant lesions were bypassed
in the CABG patients compared to 54% of signiﬁcant lesions
in the PCI patients [4]. In the same trial, cardiac death,
myocardial infarction and angina at 10-year follow-up were
similar in patients in whom a PCI was performed as a
planned incomplete revascularization, as compared to those
with a planned complete revascularization. Furthermore,
even in patients for whom complete revascularization with
angioplasty was planned, only 50% of lesions were both
attempted and dilated. Similar results were obtained by
Vandormael et al. who found an important symptomatic
relief achieved with partial revascularization in patients
with multivessel disease. In these patients, 1-year cardiac
event rate was not signiﬁcantly higher than the rate in the2 International Journal of Molecular Imaging
group with complete revascularization. At followup, 66% of
patients with complete revascularization were asymptomatic
and 84% had clinical improvement; this was similar to
58% and 85%, respectively, for patients with incomplete
revascularization [10]. Thus, incomplete revascularization
seems to be a valuable solution when a culprit lesion can be
identiﬁed, particularly when this vessel is a favourable lesion
which serves a large noninfarct territory, or in case of an
acute coronary syndrome where there is the need to stabilize
patient’s condition [11, 12]. Moreover, in the Arterial
Revascularization Therapies Studies (ARTS), randomization
of stenting in patients with incomplete revascularization
including diabetics did not inﬂuence late mortality [13].
However, in multivessel disease, complete revasculariza-
tion is often an achievable goal not often pursued both by
PCI and CABG, despite the fact that the latter is generally
more complete. Indeed, even when complete revascular-
ization is planned such as in the chronic total occlusion
subgroup of the Syntax Trial, complete revascularization is
obtained in only 49.4% of PCI treated patients while in only
68.1% of CABG treated patients [2].
More recently, in the ﬁve-year outcome of the ARTS II
study, there was no signiﬁcant diﬀerence in survival rates
between patients with complete and incomplete revascu-
larization treated by PCI or CABG. Conversely, this study
showed a signiﬁcantly lower free-from-MACE survival in
patients with higher SYNTAX tertiles compared to the lower
and intermediate ones [14].
3. Assessment of CardiovascularRisk after
Revascularization
Exercise testing is a widely used method particularly valuable
in assessing cardiovascular status after the occurrence of a
cardiaceventortherapeuticinterventionssuchasPCI.Itmay
provide useful information on symptoms and functional
capacity of the patient. When it is performed after discharge
it is helpful for activity counseling and/or exercise training
as part of the cardiac rehabilitation program [15]. However,
data obtained from two meta-analyses demonstrate that
exercise testing, even if information from the electrocar-
diogram and symptomatic data is synthesized, is poor
diagnostic for myocardial ischemia with a sensitivity of 46%
and a speciﬁcity of 77% [6, 7]. The use of stress nuclear
imaging increases signiﬁcantly the sensitivity to 87% and
the speciﬁcity to 78%, while that of stress echocardiography
imaging increases the sensitivity to 63% and thespeciﬁcity to
87%. The lower sensitivity of the exercise ECG compared to
imaging techniques in clinical practice is worsened further
by inadequate stress yielding low exercise heart rates, the
use of drugs that are known to inﬂuence test results, and
the extent of disease in vessels other than those dilated.
Furthermore,theexerciseelectrocardiogramdoesnotpermit
the determination of location of the ischemia, nor does it
accurately assess the extent of ischemia; these factors are
often crucial in the clinical decision making after-PCI.
Although exercise testing has the advantage of wide-
spread availability and relatively low cost, the higher test
accuracy obtained by stress imaging provides greater advan-
100
80
60
40
20
0
46%
3
3
–
5
8
87%
7
4
–
1
0
0
63%
4
5
–
1
0
0
77%
6
7
–
9
6
78%
7
4
–
8
1
87%
7
2
–
1
0
0
Sensitivity Speciﬁcity
Exercise test n = 527
Stress-nuclear n = 262
Stress-echo n = 183
(
%
)
Figure 1: Sensitivity and speciﬁcity of functional testing for the
detection of restenosis (>50% stenosis) after PCI: a meta-analysis.
Adapted from Garzon and Eisenberg, Can J Cardiol 2001 [6].
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Figure 2: Sensitivity and speciﬁcity of functional testing for the
detection of restenosis (>50% stenosis) after PCI: a meta-analysis.
Adapted from Dori et al., J Intern Med 2003 [7].
tages for clinical assessment of these patients. An additional
advantage is that pharmacological imaging stress testing may
be performed in patients who are unable to exercise or who
have an uninterpretable electrocardiogram.
Several studies [6, 7, 16–23] employing SPECT myocar-
dial perfusion imaging (MPI) at diﬀerent times from PCI
have shown high level of sensitivity and speciﬁcity of nuclear
imaging when compared to those of coronary angiography
(Figures 1 and 2). The overall performance of SPECT-MPI
for the detection of myocardial ischemia was 79% for both
sensitivity and speciﬁcity. These values improve when MPI
is performed later than 2 months after revascularization.
The decreased speciﬁcity observed when MPI is performed
prematurely after PCI was initially noted following PTCA
[24–26] and after coronary stenting [27, 28]. Indeed, MPI
may be altered as a consequence of impaired ﬂow reserve
due to an epicardial coronary stenosis or, in the absence of
coronary obstruction, as a consequence of an endothelial
dysfunctionandmedialinjuryatthetreatedsiteorabnormal
microvascular and resistive vessel function distal to the PCI
site as shown by various authors [29, 30] and by us in two
editorials [31, 32].
Similar to MPI, echocardiography in conjunction with
exercise provides useful functional assessment of coro-
nary lesions and has a high concordance with myocardialInternational Journal of Molecular Imaging 3
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Figure 3: Cardiac composite event-free survival in patients with
normal, mildly abnormal, or severely abnormal SPECT 99mTc-
tetrofosminscintigraphy.FromGalassietal.,AmJCardiol2006[8].
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Figure 4: Cardiac hard event-free survival in patients with normal,
mildly abnormal, or severely abnormal SPECT 99mTc-tetrofosmin
scintigraphy. From Galassi et al., Am J Cardiol 2006 [8].
scintigraphy [33]. Mertes and colleagues found that exercise
echocardiography may predict the development of recurrent
ischemiaafterPTCA,withasensitivityof83%andspeciﬁcity
of 85% [34]. The functional signiﬁcance of a lesion may
also be determined with the use of pharmacological stress
[35]. For the detection of coronary restenosis, exercise [36],
dipyridamole [37], and dobutamine echocardiography [38]
have shown a diagnostic accuracy similar to that seen with
MPI although a lower sensitivity (75% to 87%) and a slight
higher speciﬁcity (84% to 95%) were found in the direct
comparison with the nuclear data [36, 37]. A limitation
of stress echocardiography is the inability to get acceptable
qualityimagesofleftventriclewallsinabout15%ofpatients.
This problem can be solved by using dobutamine magnetic
resonance imaging. Indeed, if this exam is performed at
institutions and interpreted by physicians with adequate
experience and training, it is considered of major impor-
tance for coronary artery disease detection and, along with
gadolinium, for viability detection to predict left ventricular
function recovery [39].
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Figure 5: Cardiac soft event-free survival in patients with normal,
mildly abnormal, or severely abnormal SPECT 99mTc-tetrofosmin
scintigraphy. From Galassi et al., Am J Cardiol 2006 [8].
4. Stress Imagingafter AnatomicalComplete or
Incomplete Revascularization
Both MPI and stress echocardiography have a clear supe-
riority with regard to speciﬁcity and predictive value for
postrevascularization events [40–44]. Indeed, for MPI, these
ﬁndings have been shown regardless of the method selected
and include the use of 201Tl or 99mTc radiopharmaceuticals
or after the use of diﬀerent modes of stress imaging [45–
48]. In the Angioplasty Compared to Medicine Study, 328
patients were randomized to PTCA or to medical therapy. At
six months after randomization, 82% of patients underwent
stress MPI and were followed for more than ﬁve years. Mor-
tality in the PTCA group was 20% for those with a reversible
defect versus 7% for those without such a defect (P = 0.03).
Bymultivariate analysis,thestrongestpredictorsofmortality
were diabetes, smoking, and a reversible perfusion defect at
MPI [46].
Similarly, the relative prognostic information derived
from MPI at 1 year after revascularization for patients
with multivessel coronary artery disease included in the
prospective EAST Trial reveals a strong correlation between
detected ischemia on thallium scintigraphy and subsequent
events [45, 47]. More recently, in patients with incomplete
revascularization procedures, we demonstrated that exercise
SPECT MPI provides signiﬁcant independent information
concerning the subsequent risk of both hard and soft cardiac
events, with a composite annualized event rate <2% for
patientswithanormalscan(Figure 3).MPIisabletoprovide
incremental prognostic information after adjusting for clini-
cal,angiographic,andexercisevariablesandisabletopredict
the occurrence of cardiac hard and soft events when separat-
ingpatientsaccordingtothepresenceofmyocardialischemia
and necrosis (Figures 4 and 5)[ 8]. The results of this study
suggest that certain high-risk patients, such as those with
multivessel coronary artery disease, treated by incomplete
revascularization may beneﬁt from routine MPI; this is
especially true for low-risk patients as shown by Ho and
colleagues who studied 211 patients between 1 and 3 years4 International Journal of Molecular Imaging
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Figure 6: Rate of death/myocardial infarction and unstable angina/repeat revascularization in patients with normal, mildly abnormal, and
severely abnormal SPECT Tc-tetrofosmin scintigraphy after a 4-year followup, in presence of CTO. MI: myocardial infarction; UA: unstable
angina, From Galassi et al., J Interven Cardiol 2010 [9].
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Figure 7: Flow chart algorithm in patients with multivessel disease. MPI: myocardial perfusion imaging.
after PCI and monitored them for 7.3 years. Despite a low
overall annual event rate of 1% per year, an abnormal MPI
was signiﬁcantly predictive of cardiac death or MI, whereas a
normal MPI was associated with low risk [49].
To date, the major evidence that supports revascular-
ization in patients with an abnormal MPI is based on
the following three studies. Hachamovitch et al. examined
a prospective database from a single center and classiﬁed
patients on the basis of the severity of ischemia on stress
MPI and examined the eﬀect of revascularization versus
medical therapy on subsequent mortality after an average
followup of two years. There was no diﬀerence in mortality
between medical therapy and revascularization in patients
with ischemia <10% of myocardium, while patients with an
ischemia >10% had lower mortality with revascularization
[50]. These results were also conﬁrmed in the nuclear sub-
study of the COURAGE trial, in which patients with stable
angina had paired MPI studies performed at baseline and 6–
18 months after randomization of optimal medical therapy
versus optimal medical therapy and PCI. A reduction of
ischemia>5%onMPIwasassociatedwitha13.4%rateofthe
death/myocardial infarction composite event rate, whereas
in those with no reduction of ischemia the composite event
rate was 27.4% (more than two-fold). Indeed, PCI was
more eﬀective in achieving an ischemia reduction of >5%
compared to medical therapy (33% versus 19.8%, P =
0.004) [51]. These two studies suggest that the beneﬁts of
revascularization over medical therapy are related rather
than to a more complete anatomical revascularization, to a
signiﬁcant reduction of ischemia, revascularization driven.
Similarly, in a recent study by our group in patients with
a residual CTO in a main coronary artery left untreated after
PCI whounderwent follow-upstressMPI,myocardial perfu-
sion imaging provided signiﬁcant independent informationInternational Journal of Molecular Imaging 5
concerning the subsequent risk of cardiac events. Indeed,
patientswithsevereischemiahadsigniﬁcantlyhigherratesof
death and myocardial infarction than those with either mild
ischemia or no ischemia. Furthermore, by characterizing
the type of defect in terms of presence of scar, ischemia
only, or scar and ischemia, we observed that patients with
ischemia had the worst outcomes. This study emphasizes
the prognostic signiﬁcance of ischemia on stress MPI even
in patients with chronically occluded coronary vessels, so
refocusing the attention on the diﬀerence between anatomic
and functional revascularization [9]. This study, with all
others from literature, underlines that it is not the anatomic
severity of coronary disease which determines prognosis,
rather the achievement of a “functionally” complete revas-
cularization, in other words revascularization of all coronary
arteries which serve only ischemic and viable myocardial
segments [9, 13, 52, 53]( Figure 6). This is why many studies
evaluating the impact of completeness of revascularization
strategy based only on anatomic criteria (coronary stenosis
≥50%) have failed to demonstrate improvements in survival
rates.
5. Conclusions
Although complete revascularization remains a desirable
goal in multivessel disease patients, incomplete revascular-
ization strategy may be a preferred treatment strategy and a
commonclinicalpracticeinmanyselectedcases,whenwisely
chosen, because of its easier achievement and lower immedi-
ate risk. Among these incompletely revascularized patients,
MPI is able to identify those patients with ischemic and
viable myocardial regions, in which a “functionally complete
revascularization” is needed to improve their outcome
(Figure 7).
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